Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘25 |
|
|---|---|---|---|---|---|
| $10.9M | $14M | $3.09M | 0.26% |
|
|
| $10.8M | $11M | $233K | 0.41% |
|
|
| $10.8M | $15.8M | $5.04M | 62% |
|
|
179
Recursion Pharmaceuticals
RXRX
$1.81B
| $10.6M | $40.1M | $29.5M | 16.4% |
|
| $10.6M | $22M | $11.4M | 9.28% |
|
|
| $10.5M | $12.3M | $1.8M | 7.85% |
|
|
| $10.5M | $31.3M | $20.8M | 16.8% |
|
|
| $10.5M | $28.7M | $18.3M | 28.3% |
|
|
| $10.4M | $13.2M | $2.87M | 38.3% |
|
|
| $10.4M | $16.4M | $6.09M | 14.3% |
|
|
186
Intellia Therapeutics
NTLA
$1.59B
| $10.3M | $33.7M | $23.4M | 49.9% |
|
| $10.3M | $28.3M | $18M | 44.5% |
|
|
| $10.3M | $16.2M | $5.93M | 4.89% |
|
|
| $10.3M | $38.5M | $28.2M | 28.4% |
|
|
| $10.2M | $29.9M | $19.7M | 2.4% |
|
|
| $10.2M | $14.2M | $4.04M | 23.9% |
|
|
| $10.1M | $54.8M | $44.6M | 11.8% |
|
|
| $10.1M | $16.5M | $6.43M | 57.5% |
|
|
| $10M | $26.2M | $16.1M | 3.83% |
|
|
| $10M | $11.8M | $1.76M | 40.6% |
|
|
| $9.97M | $20.2M | $10.2M | 15.4% |
|
|
| $9.8M | $12.6M | $2.8M | 29.7% |
|
|
| $9.73M | $13.4M | $3.69M | 88% |
|
|
| $9.71M | $19.3M | $9.57M | 64.1% |
|
|
| $9.68M | $21M | $11.3M | 10.6% |
|